Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $87,323 - $116,502
-632 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$114.09 - $145.51 $72,104 - $91,962
632 New
632 $88,000
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $82,904 - $127,530
-1,085 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$61.52 - $91.1 $66,749 - $98,843
1,085 New
1,085 $93,000
Q1 2019

May 15, 2019

SELL
$35.52 - $62.62 $78,144 - $137,764
-2,200 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$35.43 - $56.29 $77,768 - $123,556
2,195 Added 43900.0%
2,200 $86,000
Q3 2018

Nov 14, 2018

SELL
$44.22 - $75.47 $187,360 - $319,766
-4,237 Reduced 99.88%
5 $0
Q4 2017

Feb 14, 2018

BUY
$65.94 - $93.31 $279,717 - $395,821
4,242
4,242 $293,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.